Status:
COMPLETED
Effectiveness of Hospital Fit on Physical Activity of Hospitalised Patients
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Radboud University Medical Center
Conditions:
Cardiovascular Diseases
Oncology
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to investigate the effectiveness of using Hospital Fit as part of the physiotherapy treatment on average time spent walking per day in patients hospitalised at t...
Detailed Description
Rationale: Physical inactivity is a major, underrecognised problem in patients during their hospital stay. Patients spend between 87 and 100% of their time lying or sitting. This physical inactivity h...
Eligibility Criteria
Inclusion
- Inclusion Criteria patients:
- Over 18 years old.
- Receiving physiotherapy at the Medical Oncology Department or the Cardiology Department at the MUMC+ or Radboudumc.
- Enough understanding of the Dutch language.
- Owning a smartphone (operating system: at least iOS 13.0 or Android 8.0).
- Able to use a smartphone app.
- Able to walk independently 2 weeks before admission, as scored on the Functional Ambulation Categories (FAC \>3).
- Exclusion Criteria patients:
- A contraindication to walking (as reported by a medical specialist in the electronic medical record).
- A contraindication to wearing an activity monitor, fixed by a hypoallergenic plaster at the upper leg (such as active bilateral upper leg infection, severe oedema or bilateral transfemoral amputation).
- Admitted for cancers of the head and neck (i.e., cancer in the oral cavity, throat (pharynx), voice box (larynx), paranasal sinuses and nasal cavity, salivary glands).
- Admitted with cardiac arrhythmia and hemodynamic instability requiring medication over 48 hours (i.e., beta blockers or noradrenaline) or invasive treatment (i.e., pacemaker or defibrillator implementation).
- Mentally incapacitated subjects as reported by healthcare professionals in the medical record. When any doubt arises, the patient will be excluded.
- Impaired cognition (delirium / dementia) as reported in the medical record by a healthcare professional. When any doubt arises, the patient will be excluded.
- Unable to participate in the informed consent procedure or unable to provide written informed consent.
- A life expectancy shorter than 3 months as mentioned by the medical specialist in the medical record.
- Previous participation in this study.
- Inclusion Criteria healthcare professionals:
- Employed as physiotherapist, nurse or physician (assistant) at the Medical Oncology Department or the Cardiology Department.
- Working at the MUMC+ or Radboudumc for at least one month.
- Exclusion Criteria healthcare professionals:
- • No participation in care for patients at the Medical oncology Department or Cardiology Department during the intervention phase (e.g., absence or research employment).
Exclusion
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05378724
Start Date
August 1 2022
End Date
March 31 2023
Last Update
April 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 EZ
2
MaastrichtUMC
Maastricht, Limburg, Netherlands, 6229 HX